T1	Participants 15 36	chronic heart failure
T2	Participants 244 270	chronic heart failure (HF)
T3	Participants 358 399	two large populations of patients with HF
T4	Participants 496 655	1457 patients enrolled in the Controlled Rosuvastatin Multinational Trial in HF (CORONA) and 1233 patients enrolled in the GISSI-Heart Failure trial (GISSI-HF)
T5	Participants 1026 1090	females, in older patients, and those with lower body mass index
T6	Participants 1715 1739	patients with chronic HF
